Injection Solvent Effects: How Diluent Strength and Injection Volume Distort Peaks

A sample diluent stronger than the mobile phase carries the analyte band through the column inlet inside the injected plug until that plug is diluted, so peaks front, broaden or split, early eluters worst.1,2 The damage scales with injection volume and strength mismatch together; diluting the strong solvent or injecting less improves peak shape.3,4

What happens when a sample diluent stronger than the mobile phase is injected?

With conventional fixed-loop or flow-through-needle injectors, the sample is spliced into the mobile phase stream, and as it enters the column it can occupy a significant fraction of the column volume with a composition close to that of the vial.5 The mismatch that usually matters is the organic fraction, in reversed-phase and hydrophilic interaction liquid chromatography (HILIC) separations alike, although pH and ionic strength mismatches can also be important.5

The injected plug must be diluted to mobile-phase composition before normal retention can occur.6 A stronger plug sweeps analyte molecules through the first part of the column faster than normal and smears the band; a weaker plug slows them and concentrates them at the inlet.1,6 When a 40 µL injection filled about 70% of a column’s dead volume, most compounds simply traveled with the sample-solvent band from inlet to outlet.4 Figure 1 shows this chain from vial to column head.

Icon chain of sample vial, injector and column head showing a strong sample diluent plug carrying the analyte band into the column and smearing it, contrasted with a weaker diluent plug that concentrates the band at the column inlet.
Figure 1. How a strong diluent carries the analyte band into the column. Icon chain from sample vial to injector to column head, with arrows for the sequential flow path. Top row: the plug of strong diluent enters the column head at near-vial composition and carries the analyte band forward, smearing it until the plug is diluted to mobile-phase composition.5,6 Bottom row: a weaker plug slows the analyte and concentrates it at the inlet.6 Vial and plug color mark diluent strength: orange stronger, blue weaker than the mobile phase. Both plugs are drawn the same length (same injection volume). Plug and band lengths are illustrative and not scaled to any column. Schematic, not data.
Build it faster

AI Method Builder

Draft a starting method for your separation and refine it — save your work to your account.

Build my starting method
No account needed

Which peak shapes point to an injection solvent effect?

Strong injection solvents have been blamed for fronting, tailing, band broadening and other distortions.2 USP General Chapter ⟨621⟩ calls a peak fronting when its symmetry factor As is below 1.0.7 The distortion is usually worse for early peaks and less obvious or absent for later ones.1,3 A split can hide: one early-eluting hydrophilic impurity showed only a slight front foot, yet in-line mixers revealed that a significant fraction of its mass eluted at the hold-up time (dead time).8 Table 1 lists reported symptoms and conditions.

Table 1. Peak symptoms of strong diluents and large injection volumes as reported in the cited cases; observed examples under each source’s conditions, not a model.
Symptom Reported conditions Separation mode
Preceding bulge (fronting) that grows with diluent strength Caffeine; acetonitrile in the diluent raised to 66% and 100%3 Reversed phase, fast gradient
Broader, distorted peaks at shorter retention 30 µL of acetonitrile injected into an 18% acetonitrile mobile phase6 Reversed phase, isocratic
Loss of all resolution Diluent with 20% more acetonitrile than the starting gradient5 Reversed phase, gradient
Split peaks with mass eluting at the hold-up time 20 µL of aqueous sample8; early hydrophilic impurity without an in-line mixer8 HILIC; reversed phase
Tailing and broadening of early peaks with a matched diluent 40 µL, about 70% of the column dead volume5 Reversed phase, gradient

Figure 2 arranges the same symptoms by diluent strength.

Four schematic chromatogram panels of the same analyte showing injection solvent effects by diluent strength: a tall narrow peak for a weaker diluent, a symmetric peak for a matched diluent, a fronting broadened peak for a stronger diluent and a split peak with breakthrough at the hold-up time for a much stronger diluent at large volume.
Figure 2. Stronger diluents front, broaden and split early peaks. Four icon panels show one early-eluting analyte drawn with equal total peak area. Vial color shows diluent strength; orange marks the distorted part of each trace. A diluent weaker than the mobile phase gives a narrower, taller peak.6 A matched diluent gives a symmetric peak. A stronger diluent gives a broadened peak with a preceding bulge.3 A much stronger diluent at large volume splits the peak and sends part of the mass out at the hold-up time tM, so the same area is divided between two peaks.8 Strength ordering is drawn for reversed phase; in HILIC, water is the strong solvent.5 Schematic traces, not data.

Rule out other causes on the diagnostic path for tailing HPLC peaks before blaming the diluent.

How do injection volume and diluent strength interact?

The influence of the injection solvent depends on both its volume and how far its composition differs from the mobile phase.6,5 A small volume of a strong solvent is diluted quickly and matters little, while a large volume of the same solvent is more damaging.6 The fast-gradient study by Layne and colleagues found performance compromised as a function of both injection volume and diluent strength.3

Vinj < 0.01 × VM

where Vinj is the injection volume and VM is the column hold-up volume (dead volume). As a working rule, Stoll advises keeping injections below about 1% of the dead volume, where the sample solvent has little effect on the separation.5,4 For a 50 mm × 2.1 mm column with a dead volume of about 100 µL, that limit is ≈1 µL.5

For injection in mobile phase, a second working rule keeps the volume below 15% of the volume of the first peak of interest for less than 1% loss in resolution, or below 40% for a 10% loss.6,1 Volume loading capacity increases with a longer column or a wider column of the same length.3 Table 2 sets these rules beside their basis and scope.

Table 2. Published working rules for injection volume and diluent strength, with each rule’s stated basis and scope; practitioner heuristics, not requirements.
Working rule Stated basis Scope
Injection < ≈1% of the column dead volume Sample solvent then has little effect4,5 Rule of thumb; any diluent
Injection < 15% of the first peak’s volume <1% loss in resolution6,1 Injection in mobile phase only
Injection < 40% of the first peak’s volume 10% loss in resolution6 Injection in mobile phase only
Diluent weaker than the starting gradient 20% less acetonitrile restored a separation that 20% more ruined9 One alkylphenone example; too much weak solvent risks precipitation9

For validated or compendial methods, the applicable procedure and regulatory framework take precedence over the general rules of thumb given here.

Why is water the strong sample solvent in HILIC?

In HILIC the roles invert: water is a very strong solvent, so the water content of the sample matters more than its organic content.5,4 The weak solvent added to dilute a sample is accordingly water in reversed phase and acetonitrile in HILIC.9 In one HILIC example, 20 µL of aqueous sample, about 20% of the column volume, split cytidine and guanosine and sent part of their mass through at the hold-up time; a 95:5 acetonitrile:water diluent fixed it.8 Stoll attributes many reports of no retention in HILIC to this combination of injection volume and diluent composition rather than to low retention.4

A systematic study of HILIC sample diluents found the dissolution solvent more critical than in reversed phase and recommends the lowest amount of water in the diluent.10 Acetonitrile-rich diluents carry a recovery risk: thiamine and cyanocobalamin gave roughly 50% of their water-diluent peak areas from 90:10 acetonitrile/water, which the authors attribute to incomplete solubility.9 Weigh these trade-offs when choosing between reversed phase and HILIC.

How do you confirm and fix an injection solvent problem?

Two tests separate strength from volume. Re-injecting in the mobile phase, or the starting gradient composition, tests strength: diluents no stronger than the mobile phase left retention times unchanged, while too strong a solvent gave broader, distorted peaks at shorter retention.6 Changing the injection volume twofold tests volume, an empirical check Dolan and Alsehli recommend.6 Table 3 links each result to a remedy.

Table 3. Decision table for an injection solvent effect: each test, the result that implicates the injection and the matching remedy.
Test Result Interpretation Remedy
Re-inject in mobile phase (or the starting gradient composition) Normal shape and retention6 Diluent strength Weaker diluent, or match the starting conditions1,10
Halve the injection volume Narrower peaks6 Injection volume Inject less, toward ≈1% of the dead volume5
Check solubility in the weaker diluent Precipitation or phase separation9 Diluent cannot be weakened offline In-line mixer or at-column dilution8,9
Neither test changes the peak No change Not an injection effect General peak-shape diagnosis

Figure 3 draws the same four rows.

Four-row workflow for diagnosing an injection solvent effect: re-inject in mobile phase, halve the injection volume, check solubility in a weaker diluent and the no-change case, each leading through its result and interpretation to a remedy.
Figure 3. Diagnostic workflow for an injection solvent effect. Four rows reproduce Table 3; arrows run only from test to result to interpretation to remedy within a row, and the tests are independent checks. Re-injecting in mobile phase tests diluent strength and halving the volume tests injection volume.6 A solubility check decides between a weaker diluent and in-line or at-column dilution.8,9 The ≈1% of dead volume target is a working rule, not a requirement.5 Orange marks interpretations that implicate the sample diluent or the injection; gray marks the no-change case. Schematic icons, not data.

Diluting a strong solvent and injecting a proportionally larger volume improved performance under fast gradients.3 Where eluent-like diluents precipitate sample components, an in-line mixer between injector and column, or at-column dilution with an auxiliary pump, dilutes the plug after injection.8,9 Neue and colleagues developed at-column dilution for preparative loading, where samples are often poorly soluble in the starting mobile phase.11 These in-line approaches work best for analytes strongly retained in weak solvent, and mixer volume has to be chosen by experiment.5,8 For moderately retained analytes, in-line mixing made the problem worse in one HILIC study.5 If neither test changes the peak, work through the wider causes in the HPLC poor peak shapes guide.

In a compendial method, USP General Chapter ⟨621⟩ allows the injection volume to be varied provided system suitability criteria remain within their established limits.7 Changes other than those indicated require revalidation of the procedure.7 For how ⟨621⟩ treats column and method changes more broadly, see choosing an HPLC column for a regulated method. For validated or compendial methods, the applicable procedure and regulatory framework take precedence over the general rules of thumb given here.

Frequently asked questions

Is a diluent weaker than the mobile phase always safe?

For peak shape it usually helps. Dolan notes that injecting in a weaker solvent, with less organic for reversed phase, is usually alright, and a weak plug concentrates analytes at the column inlet.1,6 The risk moves to the vial: too much weak solvent can precipitate analytes or split the sample into two phases, so the injected aliquot no longer represents the sample.9 In one reversed-phase test, butyrophenone and octanophenone peak areas fell sharply below 40% acetonitrile in the diluent.9 Simple screening of peak areas across diluent compositions finds the limit for each compound.9

Is the distortion caused by solvent strength or by viscosity?

The literature is split. Layne and colleagues concluded from fast-gradient experiments on ODS columns that sample solvent strength, not viscosity, caused the effects they measured.3 Keunchkarian and colleagues found that strong solvents of exactly equal viscosity broadened bands but did not distort them, and they describe the attribution between viscosity and strength as still controversial.2 In their viscous-fingering account, an injection solvent less viscous than the eluent is expected to distort the peak front.2

Can the injection volume be reduced in a USP method without revalidation?

USP General Chapter ⟨621⟩ allows the injection volume to be varied even without a column dimension change, provided system suitability criteria remain within their established limits.7 When the volume is decreased, special attention goes to the limit of detection and the repeatability of the peak responses.7 An increase is permitted provided linearity and resolution of the peaks remain satisfactory.7 Changes other than those indicated require revalidation of the procedure.7 A smaller injection that cures fronting therefore still has to pass the method’s system suitability test.

Do large molecules react more strongly to diluent strength?

Generally, yes. Stoll notes that both the degree of the volume-overload problem and the ease of fixing it are usually exaggerated with large molecules, because their retention depends more strongly on solvent composition.12 In a gradient running only from 10% to 20% acetonitrile, a sample containing just 5% more acetonitrile than the starting point can give disastrous chromatography.12 The same sensitivity makes the fix easy: diluting that sample 1:1 with water lowers it to 7.5% acetonitrile and the problem disappears.12

Does a diluent matched to the starting gradient give the tallest peaks?

Matching the diluent to the mobile phase, or to the starting composition of a gradient, is the ideal Dolan describes for avoiding distortion.1 It does not give the tallest peaks. In Dolan and Alsehli’s example, peaks from 30 µL injections in mobile phase were 60–70% as tall as those from 30 µL injections in water.6 In their two methods, switching the diluent from methanol to water left peak areas within 0.1% but raised peak heights by about 30%.6

The takeaway

Treat a distorted early peak as an injection question before a column question: the analyte rides a strong plug until it is diluted, and the damage scales with volume and strength together.6 Re-inject in mobile phase and halve the volume to tell which lever matters, then weaken the diluent, inject less or dilute in line, remembering that in HILIC the strong solvent is water and that over-dilution can cost recovery.6,5,9

References

  1. Dolan JW. Distorted peaks – a case study. LCGC North America. 2015;33(7). https://www.chromatographyonline.com/view/distorted-peaks-case-study — supports: injecting in a diluent that matches the mobile phase (or the starting gradient conditions); strong solvents rush the sample through the column inlet; the symptoms (broad, split, doubled peaks), worst for early eluters; and the 15%-of-peak-volume rule of thumb.
  2. Keunchkarian S, Reta M, Romero L, Castells C. Effect of sample solvent on the chromatographic peak shape of analytes eluted under reversed-phase liquid chromatogaphic conditions. Journal of Chromatography A. 2006;1119(1-2):20–28. https://doi.org/10.1016/j.chroma.2006.02.006 — supports: fronting, tailing and broadening attributed to strong diluents; the competing viscous-fingering explanation (strength broadens, a viscosity mismatch distorts); and the largest effects for early eluters.
  3. Layne J, Farcas T, Rustamov I, Ahmed F. Volume-load capacity in fast-gradient liquid chromatography: effect of sample solvent composition and injection volume on chromatographic performance. Journal of Chromatography A. 2001;913(1-2):233–242. https://doi.org/10.1016/S0021-9673(00)01199-7 — supports: performance depends on both injection volume and diluent strength, with early eluters most affected; diluting the strong solvent and injecting a proportionally larger volume improves results; a front bulge as acetonitrile in the diluent increases; and their conclusion that strength rather than viscosity is responsible.
  4. Stoll DR. What’s trending in LC troubleshooting? LCGC Asia Pacific. 2019;22(1). https://www.chromatographyonline.com/view/what-s-trending-lc-troubleshooting-1 — mechanism (analytes travel with the sample-solvent band); volume × composition interaction; HILIC water-content inversion; 1% of dead volume rule of thumb.
  5. Stoll DR. More tools for sample injection when faced with mobile phase/sample solvent mismatch. LCGC International. 2026. https://doi.org/10.56530/lcgc.int.qi7889h4 — supports: the plug occupying a fraction of the column volume; volume-only broadening of early peaks; the combined volume × mismatch effect; the ≈1%-of-dead-volume advice; water as the strong solvent in HILIC; and that in-line dilution works best for strongly retained analytes.
  6. Dolan JW, Alsehli B. The role of the injection solvent. LCGC Europe. 2012;25(10). https://www.chromatographyonline.com/view/role-injection-solvent-0 — supports: the plug-dilution mechanism (a strong plug smears the band; a weak plug concentrates it at the inlet); the dependence on both volume and strength; the <15% peak-volume rule; and the twofold volume test.
  7. United States Pharmacopeia. General Chapter ⟨621⟩ Chromatography, Stage 4 harmonization (official 1 December 2022). https://www.usp.org/sites/default/files/usp/document/harmonization/gen-chapter/harmonization-november-2021-m99380.pdf (accessed 2026-10-18) — supports: the allowable injection-volume adjustment and its conditions in compendial LC methods; changes outside the listed adjustments require revalidation; and the symmetry-factor definition of fronting.
  8. Stoll DR. Mixing and mixers in liquid chromatography, part III: solutions for problems with sample diluents. LCGC North America. 2019;37(6). https://www.chromatographyonline.com/view/mixing-and-mixers-liquid-chromatography-part-iii-solutions-problems-sample-diluents — diluent/eluent mismatch above ≈1% of dead volume; HILIC water-diluent splitting and breakthrough at dead time; diluent change and in-line mixer as remedies; precipitation limitation.
  9. Stoll DR, Mack AE. Effects of sample diluent on analyte recovery in reversed-phase and HILIC separations. LCGC North America. 2019;37(9). https://www.chromatographyonline.com/view/mind-diluent-effects-sample-diluent-analyte-recovery-reversed-phase-and-hilic-separations — supports: a diluent 20% stronger vs 20% weaker in acetonitrile than the starting conditions; the HILIC inversion (an aqueous sample gives poor peaks); dilution with weak solvent offline or at-column; and the precipitation risk of over-dilution.
  10. Ruta J, Rudaz S, McCalley DV, Veuthey JL, Guillarme D. A systematic investigation of the effect of sample diluent on peak shape in hydrophilic interaction liquid chromatography. Journal of Chromatography A. 2010;1217(52):8230–8240. https://doi.org/10.1016/j.chroma.2010.10.106 — supports: in HILIC the diluent is more critical than in reversed phase and water in the diluent should be minimized; in reversed phase, dissolve in the mobile phase or a weaker solvent.
  11. Neue UD, Mazza CB, Cavanaugh JY, Lu Z, Wheat TE. At-column dilution for improved loading in preparative chromatography. Chromatographia. 2003;57(Suppl 1):S121–S127. https://doi.org/10.1007/BF02492093 — supports: at-column dilution as a sample-introduction technique that gets around limited sample solubility under preparative conditions.
  12. Stoll DR. Essentials of LC troubleshooting, part VII: how wide should those peaks be? (large molecule edition). LCGC International. 2025;2(5):26–29. https://doi.org/10.56530/lcgc.int.zu2182c7 — definition of volume overload (volume and sample-solvent composition); small excess of acetonitrile over gradient start; 1:1 water dilution remedy; effect larger for large molecules.

Further reading

  • Snyder LR, Kirkland JJ, Dolan JW. Introduction to Modern Liquid Chromatography. 3rd ed. Wiley.
  • Neue UD. HPLC Columns: Theory, Technology, and Practice. Wiley-VCH.

Reviewed against cited sources. The plug-dilution mechanism follows Dolan and Alsehli, Dolan and Stoll’s LCGC columns; the symptoms follow Layne et al., Keunchkarian et al., Dolan and Stoll; the volume and strength working rules follow Stoll and Dolan and are labeled as heuristics; the HILIC statements follow Stoll, Stoll and Mack and Ruta et al.; at-column dilution follows Neue et al. and Stoll and Mack; the strength-versus-viscosity debate follows Layne et al. and Keunchkarian et al.; compendial statements follow USP General Chapter ⟨621⟩. For validated or compendial methods, the applicable procedure and regulatory framework take precedence over the general rules of thumb given here. Evidence review: October 2026.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Scroll to Top